Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser, and may not function properly. More information here...
    Comp Hepatol. 2007 May 1;6:4.

    CIDE-A is expressed in liver of old mice and in type 2 diabetic mouse liver exhibiting steatosis.

    Source

    Edison Biotechnology Institute, Ohio University, Athens, OH 45701, USA. kelder@ohio.edu

    Abstract

    BACKGROUND:

    Increased levels of circulating fatty acids caused by insulin resistance and increased adipocyte lipolysis can accumulate within the liver resulting in steatosis. This steatosis sensitizes the liver to inflammation and further injury which can lead to liver dysfunction. We performed microarray analysis on normal mouse liver tissue at different ages and type 2 diabetic liver exhibiting steatosis to identify differentially expressed genes involved in lipid accumulation and liver dysfunction.

    RESULTS:

    Microarray analysis identified CIDE-A as the most differentially expressed gene as a function of age. Mice fed a high fat diet developed hyperinsulinemia, hyperglycemia and liver steatosis, all features of the human metabolic syndrome. Increased CIDE-A expression was observed in type 2 diabetic liver and the elevated CIDE-A expression could be reversed by weight loss and normalization of plasma insulin. Also, CIDE-A expression was found to be correlated with hepatic lipid accumulation.

    CONCLUSION:

    The corresponding increase in CIDE-A expression with hyperinsulinemia and liver steatosis suggests a novel pathway for lipid accumulation in the liver.

    PMID:
    17472743
    [PubMed]
    PMCID:
    PMC1868770
    Free PMC Article

      Supplemental Content

      Icon for BioMed Central Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk